Segmentation by type classifies wearable bio sensors according to their underlying sensing technology and data acquisition methodology, which directly influences cost structure, regulatory classification, and integration complexity. Electrochemical sensors—primarily used for glucose, lactate, and electrolyte tracking—represent roughly 40% of the market, owing to their high specificity and mature manufacturing base. Optical sensors, including photoplethysmography (PPG) and near‑infrared spectroscopy, account for about 30%, driven by their non‑invasive nature and suitability for heart‑rate, SpO₂, and tissue oxygenation monitoring. Mechanical sensors, such as piezoelectric and strain‑gauge devices, contribute 18%, supporting motion‑based diagnostics and respiratory effort measurement. Acoustic sensors, which capture phonocardiograms and lung sounds, occupy the remaining 12%, reflecting emerging interest in sound‑based diagnostics. Each sensor type adds distinct value to the overall Wearable Bio Sensors for Healthcare Monitoring market, shaping product portfolios, R&D investment, and competitive dynamics across the ecosystem.